EDN1 and hypertensive disorder: Recent research discovered that sargachromenol-D, a dual L-type calcium channel blocker/ET A/B2 antagonist, obtained from the marine brown alga Sargassum siliquastrum, lowers ET-1 and K+ depolarization-induced vasoconstriction in rabbit basilar arteries and lowers BP in rodent models of hypertension.